Showcases Stock ranks

AbbVie Inc. (ABBV)
84.27 -3.7 (-4.21%) 10-22 16:02
Open: 88.53 Pre. Close: 87.97
High: 88.53 Low: 83.5
Volume: 7,621,062 Market Cap: 127608M
Share on Facebook   Tweet this page   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 88.719 - 89.252 89.252 - 89.648
Low: 82.273 - 82.954 82.954 - 83.461
Close: 83.364 - 84.371 84.371 - 85.119
Stock Technical Analysis
Target: Six months: 106.98
One year: 112.83
Support: Support1: 83.50
Support2: 69.47
Resistance: Resistance1: 91.60
Resistance2: 96.60
Pivot: 91.85
Moving Averages: MA(5): 89.26
MA(20): 92.47
MA(100): 94.83
MA(250): 99.08
MACD: MACD(12,26): -1.74
%K %D: %K(14,3): 6.26
%D(3): 19.04
RSI: RSI(14): 28.11
52-Week: High: 125.86
Low: 83.5
Change(%): -8.1
Average Vol(K): 3-Month: 512127
10-Days: 545142
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

ABBV has closed below the lower band by 12.7%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 54.8% wider than normal. The large width of the bands suggest high volatility as compared to ABBV's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
AbbVie's Upadacitinib Shows Significant Improvements in Physical Function, Pain and Quality of Life as a Monotherapy in Patients with Rheumatoid Arthritis in Phase 3 Patient-Reported Outcomes Data

Dividend Sensei's Portfolio Update 56: The Smart Way To Win A $1.6-Billion Jackpot

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1514.27
Shares Float (M) 1512.96
% Held by Insiders 0.10
% Held by Institutions 71.90
Shares Short (K) 31008
Shares Short Prior Month (K)
Stock Financials
EPS 6.760
EPS Est. Current Year 5.530
EPS Est. Next Year 6.560
EPS Est. Next Quarter 1.440
Forward EPS 8.888
Book Value (p.s.) 39.310
PEG Ratio 0.74
Profit Margin 20.12
Operating Margin 36.57
Return on Assets (ttm) 10.0
Return on Equity (ttm) 487.4
Qtrly Rev. Growth 19.2
Gross Profit (p.s.) 7.157
Sales Per Share
EBITDA (p.s.) 3.056
Qtrly Earnings Growth 3.60
Operating Cash Flow (M) 11370.00
Levered Free Cash Flow (M) 9330.00
Stock Valuation
P/E 12.46
P/E Growth Ratio -0.04
P/BV 2.14
P/S 6528096256.00
P/CF 11.22
Dividend Yield 0.05
Dividends & Splits
Dividend 4.365
Dividend Pay Date 2018-11-15
Ex-Dividend Date 2018-10-12
Forward Dividend 3.840
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator